Search for: "Roche Therapeutics, Inc." Results 41 - 51 of 51
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Sep 2011, 8:40 am by Peter Rost
He also provides consulting services on corporate therapeutics and ethics guidelines. [read post]
14 Sep 2011, 12:07 pm by Peter Rost
He also provides consulting services on corporate therapeutics and ethics guidelines. [read post]
2 Oct 2010, 8:43 am by Peter Rost
Peter Rost is a former Pfizer Marketing Vice President providing services as an expert witness on pharmaceutical marketing and consulting services on corporate therapeutics and ethics guidelines. [read post]
15 Feb 2012, 7:42 am by Peter Rost
He also provides consulting services on corporate therapeutics and ethics guidelines. [read post]
14 Sep 2011, 12:08 pm by Peter Rost
He also provides consulting services on corporate therapeutics and ethics guidelines. [read post]
11 Feb 2011, 7:51 am by Peter Rost
Peter Rost is a former Pfizer Marketing Vice President providing services as an expert witness on pharmaceutical marketing and consulting services on corporate therapeutics and ethics guidelines. [read post]
30 May 2012, 1:37 pm by Peter Rost
He also provides consulting services on corporate therapeutics and ethics guidelines. [read post]
22 Jun 2011, 7:09 am by Peter Rost
He also provides consulting services on corporate therapeutics and ethics guidelines. [read post]
14 Sep 2011, 12:07 pm by Peter Rost
He also provides consulting services on corporate therapeutics and ethics guidelines. [read post]
14 Sep 2011, 12:08 pm by Peter Rost
He also provides consulting services on corporate therapeutics and ethics guidelines. [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]